摘要 ［摘要］目的: 探讨氯丙咪嗪促进人脑胶质瘤U251细胞凋亡的可能机制。方法: 用甲基噻唑基四唑（MTT）比色法检测不同浓度（228、114、57、28.5、14.25 μmol/L）的氯丙咪嗪对U251细胞增殖活性的影响，选取57、28.5 μmol/L浓度组进行台盼蓝染色、细胞凋亡染色、流式细胞仪检测，采用蛋白质印迹法和免疫荧光染色法检测细胞中转位分子蛋白（translocator protein, TSPO）的表达，2′, 7′-二氢二氯荧光黄双乙酸钠(DCFH-DA)探针法检测细胞内活性氧的水平，荧光素酶法检测细胞内ATP含量。结果：  氯丙咪嗪组细胞死亡率及凋亡率明显增加，且一定范围内与药物浓度相关；与对照组相比，氯丙咪嗪组TSPO的表达明显增加（P<0.05)，活性氧生成明显增加,而细胞内ATP含量明显降低（P<0.05)。 结论： 氯丙咪嗪可能通过增加细胞内TSPO的表达及活性氧水平，降低ATP含量而促进U251细胞凋亡。 Abstract ： [Abstract]Objective: To explore the possible mechanism of chlorimipramine on human brain glioma U251 cell apoptosis. Methods: Using methyl thiazolyl tetrazolium(MTT) colorimetry with different concentrations of chlorimipramine to test the effects of chlorimipramine on human brain U251 glioma cells; based on the results, selecting two group of different concentrations for the detection of relevant indicators, including death count of trypan blue staining cell, apoptosis staining, the detection of flow cytometry. Additionally, Western blotting and immumofluorescence assay were conducted to examine the expression level of translocator protein(TSPO). DCFHDA probe was performed to examine the level of reactive oxygen species (ROS) and luciferase assay was applied to investigate cell mitochondrial membrane potential. Results: Based on the testing results of MTT, selecting chlorimipramine 57, 28.5 μmol/L, the concentrations of which have statistically significant differences; then putting them into the following tests: trypan blue staining, cell apoptosis staining, and flow cytometry. All the testing results confirmed that chlorimipramine had significantly inhibiting effects on human brain U251 glioma cells, and with a certain degree, the effects were associated with the drug concentration. Additionally, comparing with the control group, Western blotting analysis and immumofluorescence demonstrated that the expression level of TSPO was significantly increased in the groups of chlorimipramine（P<0.05).The level of ROS was significantly higher, but ATP quantity decreased significantly（P<0.05). Conclusion: Chlorimipramine could significantly inhibit human U251 glioma cell growth, promote apoptosis by increasing the expression level of TSPO,ROS and decreasing ATP quantity. Chlorimipramine has good antiglioma effects, and could be used as a kind of candidate drug for the treatment of glioma chemotherapy. 朱勋1，王菁哲1，陈品2，王存祖1，许慧中3，欧阳琦1. 氯丙咪嗪对脑胶质瘤U251细胞活性的抑制作用及机制[J]. 江苏大学学报:医学版, 2016, 26(02): 132-136. ZHU Xun1, WANG Jing-zhe1, CHEN Pin2, WANG Cun-zu1, XU Hui-zhong3, OUYANG Qi1. Inhibition effects of chlorimipramine on human brain U251 glioma cells and its potential mechanism. Journal of Jiangsu University(Medicine Edition), 2016, 26(02): 132-136. \[1\]Bielecka AM, Obuchowicz E. Antidepressant drugs as a complementary therapeutic strategy in cancer\[J\]. Exp Biol Med (Maywood), 2013, 238(8):849-858.\[2\]Frick LR, Rapanelli M. Antidepressants: influence on cancer and immunity\[J\]. Life Sci, 2013, 92(10):525-532.\[3\]Rooprai HK, Christidou M, Pilkington GJ. The potential for strategies using micronutrients and heterocyclic drugs to treat invasive gliomas\[J\]. Acta Neurochir(Wien), 2003, 145(8): 683-690.\[4\]Daley E, Wilkie D, Loesch A, et al. Chlorimipramine: a novel anticancer agent with a mitochondrial target\[J\]. Biochem Biophys Res Commun, 2005, 328(2):623-632.\[5\]Veenman L, Shandalov Y, Gavish M. VDAC activation by the 18 kDa translocator protein (TSPO), implications for apoptosis\[J\]. J Bioenerg Biomembr, 2008, 40(3):199-205.\[6\]许慧中, 王存祖. 脑胶质瘤中TSPO与细胞凋亡的关系\[J\]. 国际神经病学神经外科学杂志, 2010, 37(6): 578-580.\[7\]Levin E, Premkumar A, Veenman L, et al. The peripheraltype benzodiazepine receptor and tumorigenicity: isoquinoline binding protein (IBP) antisense knockdown in the C6 glioma cell line\[J\]. Biochemistry, 2005, 44(29):9924-9935.\[8\]Pilkington GJ, Parker K, Murray SA. Approaches to mitochondrially mediated cancer therapy\[J\]. Semin Cancer Biol, 2008, 18(3):226-235.\[9\]Beaney RP, Gullan RW, Pilkington GJ. Therapeutic potential of antidepressants in malignant glioma: clinical experience with clomipramine\[J\]. J Clin Oncol (Meet Abstr)，2005，23（16S）:1535.\[10\]Parker KA, Glaysher S, Hurren J, et al. The effect of tricyclic antidepressants on cutaneous melanoma cell lines and primary cell cultures\[J\]. Anticancer Drugs, 2012, 23(1):65-69.\[11\]Bilir A, Erguven M, Oktem G, et al. Potentiation of cytotoxicity by combination of imatinib and chlorimipramine in glioma\[J\]. Int J Oncol, 2008, 32(4):829-839.\[12\]Higgins SC, Pilkington GJ. The in vitro effects of tricyclic drugs and dexamethasone on cellular respiration of malignant glioma\[J\]. Anticancer Res, 2010，30(2):391-397 李杨1,2， 王颖1,2， 王妍1,2， 施鑫钰1,2， 陈瑾1,2， 钱晖1,2. piR-hsa-1282在脂多糖诱导的293T细胞急性损伤中的作用 [J]. 江苏大学学报:医学版, 2019, 29(05): 386-389,393. 刘宝翠， 郑婷婷， 董利阳， 牟笑， 许铖铖， 毛朝明. 小窝蛋白-1对人甲状腺上皮细胞增殖、凋亡及胞内活性氧水平的影响 [J]. 江苏大学学报:医学版, 2019, 29(04): 282-286. 邵琦， 李佳丽， 周李宁， 苏兆亮， 许化溪. 人参炔醇重塑巨噬细胞表型调控乳腺癌细胞生物学行为 [J]. 江苏大学学报:医学版, 2019, 29(04): 287-292. 徐振雷1， 王庆伟2. 颤抖蛋白异构体7在乳腺癌中的表达及其与患者预后的关系 [J]. 江苏大学学报:医学版, 2019, 29(04): 343-346. 程洁1, 陈曦2, 唐宇1, 刘菲1, 龚爱华1. 干扰苹果酸酶3对人脑胶质瘤细胞线粒体分裂与融合的影响 [J]. 江苏大学学报:医学版, 2019, 29(03): 185-188. 纪贤严, 高建一, 叶开, 张磊, 曹江素, 胡嘉波. 人胚胎干细胞源神经球条件培养液对大鼠施万细胞增殖和迁移的影响 [J]. 江苏大学学报:医学版, 2019, 29(03): 189-194. 杨悦， 李婉， 卢春. 黑色素转铁蛋白重组慢病毒载体的构建及其在宫颈癌HeLa细胞中的功能验证 [J]. 江苏大学学报:医学版, 2019, 29(03): 216-220. 王骞1, 吕季阳2, 王艳1, 史卫群1, 吕进泉1. 曲前列环素通过下调Erk磷酸化水平抑制血小板衍生生长因子诱导的肺动脉平滑肌细胞增殖 [J]. 江苏大学学报:医学版, 2019, 29(03): 232-237. 董昕, 董利阳, 罗旋, 毛朝明. 髓相关蛋白14过表达对人甲状腺上皮细胞增殖的影响 [J]. 江苏大学学报:医学版, 2019, 29(03): 201-204. 王晖, 徐雪莹, 张徐. miR-381靶向MAP3K2抑制前列腺癌细胞增殖、迁移和侵袭 [J]. 江苏大学学报:医学版, 2019, 29(03): 208-215. 杨佩儒1, 宋廉2, 张礼荣2, 朱海涛2, 王冬青2. 人参炔醇联合吉西他滨对胰腺癌干细胞分化及活性的影响 [J]. 江苏大学学报:医学版, 2019, 29(03): 221-225. 浦梦安， 孙继芾， 束浩明， 孙勇， 黄永辉. 大鼠脊髓缺血再灌注损伤后钙敏感受体的表达变化及其抑制剂NPS2390的作用 [J]. 江苏大学学报:医学版, 2019, 29(01): 21-25. 史卫群1， 吕剑平2， 王骞2， 王艳2， 吕进泉2，*. 哮喘患儿血浆TWEAK浓度和外周血单个核细胞中NFκB活性变化及意义 [J]. 江苏大学学报:医学版, 2019, 29(01): 82-83. 卞慧琴1， 谷雨1，2， 陈瑾楠1， 王倩1， 吕耀娟1， 郑其平1， 谷俊侠1. URI在胃癌组织的表达及对顺铂诱导的胃癌细胞凋亡的影响 [J]. 江苏大学学报:医学版, 2018, 28(05): 369-375. 杨萧天1， 苏兆亮2， 徐岷1. 血管紧张素Ⅱ对结肠癌CT26细胞株增殖及侵袭的影响 [J]. 江苏大学学报:医学版, 2018, 28(04): 277-281.